概括
息护理解决了挑战性痴呆症症状和护理伴侣倦怠. 基于证据的策略可以改善痴呆症患者和家属的症状管理,提前护理规划和预后.
科学领域:
- 老年学是一门学科.
- 神经学 神经学
- 抚慰性护理是一种缓解性护理.
背景情况:
- 痴呆症给患者,照顾者和家人带来了巨大的负担,以困难的症状和未来的不确定性为标志.
- 护理伙伴的倦怠是痴呆症护理中的一个重大风险.
- 息治疗对于管理痴呆症的复杂性至关重要.
研究的目的:
- 探索痴呆症护理中常见的息护理困境.
- 审查基于证据的方法来管理痴呆症症状和护理挑战.
- 突出提前护理规划和预后的重要性.
主要方法:
- 关于痴呆症患病率,差异和治疗的最新研究的文献综述.
- 关于症状管理和药物风险/益处的证据分析.
- 探索特定于痴呆症的预先指示和生存数据.
主要成果:
- 关于痴呆病发病率的流行病学趋势和种族差异的累积研究.
- 概述了常见痴呆症药物的风险和益处,以及新的治疗选择.
- 开发用于个性化预测和探索抑郁症的工具.
结论:
- 息治疗,包括症状管理,预先护理计划和预后,对所有痴呆症患者至关重要.
- 整合息护理可以改善生活质量,并减少患者和护理人员的负担.
- 目前正在进行的研究正在完善临床实践和痴呆症患者护理策略.
相关概念视频
Continuing Care
1.8K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.8K
Alzheimer's Disease: Treatment
764
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
764
Dementia
487
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
487
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Peripheral Artery Disease III: Interprofessional Care
226
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
226
Parkinson's Disease: Treatment
945
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
945


